Malek M. Safa

522 total citations
26 papers, 357 citations indexed

About

Malek M. Safa is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Malek M. Safa has authored 26 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Malek M. Safa's work include Pancreatic and Hepatic Oncology Research (3 papers), Neutropenia and Cancer Infections (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Malek M. Safa is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), Neutropenia and Cancer Infections (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Malek M. Safa collaborates with scholars based in United States and India. Malek M. Safa's co-authors include Rami S. Komrokji, Abdul Rahman Jazieh, Zeina Nahleh, Muhammad Shaalan Beg, Bernard S. Aron, Rawia Yassin, Elyse E. Lower, Per‐Olof Hasselgren, Elizabeth Shaughnessy and Eric S. Hungness and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Malek M. Safa

25 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malek M. Safa United States 9 131 125 108 102 94 26 357
Monica Zuradelli Italy 11 89 0.7× 186 1.5× 133 1.2× 37 0.4× 54 0.6× 34 378
Piotr Skotnicki Poland 12 35 0.3× 135 1.1× 50 0.5× 108 1.1× 69 0.7× 31 392
J Berlié France 8 232 1.8× 105 0.8× 168 1.6× 86 0.8× 198 2.1× 26 501
Piero Fregatti Italy 13 105 0.8× 212 1.7× 59 0.5× 75 0.7× 21 0.2× 54 495
Valeria Forestieri Italy 10 49 0.4× 387 3.1× 78 0.7× 61 0.6× 41 0.4× 24 536
C. De Gislain France 9 176 1.3× 137 1.1× 192 1.8× 80 0.8× 141 1.5× 15 441
Nanyan Rao China 12 56 0.4× 176 1.4× 55 0.5× 84 0.8× 16 0.2× 26 373
Peter Bojko Germany 13 58 0.4× 181 1.4× 30 0.3× 43 0.4× 50 0.5× 37 523
Prashant Jani Canada 12 25 0.2× 147 1.2× 50 0.5× 209 2.0× 39 0.4× 23 498
C Lejeune France 10 37 0.3× 425 3.4× 128 1.2× 139 1.4× 25 0.3× 28 618

Countries citing papers authored by Malek M. Safa

Since Specialization
Citations

This map shows the geographic impact of Malek M. Safa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malek M. Safa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malek M. Safa more than expected).

Fields of papers citing papers by Malek M. Safa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malek M. Safa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malek M. Safa. The network helps show where Malek M. Safa may publish in the future.

Co-authorship network of co-authors of Malek M. Safa

This figure shows the co-authorship network connecting the top 25 collaborators of Malek M. Safa. A scholar is included among the top collaborators of Malek M. Safa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malek M. Safa. Malek M. Safa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matrana, Marc, Scott A. Tomlins, Khalis Mitchell, et al.. (2019). No-cost next generation sequencing of advanced cancer patients within the Strata Precision Oncology Network supports clinical trial enrollment.. Journal of Clinical Oncology. 37(15_suppl). 3073–3073. 1 indexed citations
2.
Komrokji, Rami S., Najla H. Al Ali, Muhammad Shaalan Beg, et al.. (2011). Outcome of Diffuse Large B-Cell Lymphoma in the United States Has Improved Over Time but Racial Disparities Remain: Review of SEER Data. Clinical Lymphoma Myeloma & Leukemia. 11(3). 257–260. 40 indexed citations
3.
Roddy, Julianna, et al.. (2010). Thromboembolic Events in Patients With Colorectal Cancer Receiving the Combination of Bevacizumab-Based Chemotherapy and Erythropoietin Stimulating Agents. American Journal of Clinical Oncology. 33(1). 36–42. 11 indexed citations
4.
Olowokure, Olugbenga, et al.. (2010). Is diabetes mellitus (DM) associated with worse outcomes in pancreatic cancer (PC)?. Journal of Clinical Oncology. 28(15_suppl). 4114–4114. 7 indexed citations
5.
Beg, Muhammad Shaalan, Udayakumar Navaneethan, Muslim Atiq, Rami S. Komrokji, & Malek M. Safa. (2009). Outcome of Esophageal Carcinoma in the Veteran Affairs Population. American Journal of Clinical Oncology. 32(3). 286–290. 2 indexed citations
6.
Komrokji, Rami S., Najla H. Al Ali, Muhammad Shaalan Beg, et al.. (2009). Outcome of patients with myelodysplastic syndromes in the Veterans Administration population. Leukemia Research. 34(1). 59–62. 13 indexed citations
7.
Beg, Muhammad Shaalan, Rami S. Komrokji, Kashif Ahmed, & Malek M. Safa. (2008). Oxaliplatin-induced immune mediated thrombocytopenia. Cancer Chemotherapy and Pharmacology. 62(5). 925–927. 21 indexed citations
8.
Beg, Muhammad Shaalan, et al.. (2008). Characteristics of proximal versus distal gastric cancer at the VA: Is there a difference?. Journal of Clinical Oncology. 26(15_suppl). 15517–15517. 2 indexed citations
9.
Foon, Kenneth A. & Malek M. Safa. (2008). Cancer Vaccines: Activating the Immune System to Fight Cancer. Oncology Issues. 23(4). 18–24. 2 indexed citations
10.
Atiq, Muslim & Malek M. Safa. (2007). Recurrent Hypoglycemia Associated With Poorly Differentiated Carcinoma of the Liver. American Journal of Clinical Oncology. 30(2). 213–214. 6 indexed citations
11.
12.
Nahleh, Zeina, et al.. (2007). Male breast cancer in the veterans affairs population. Cancer. 109(8). 1471–1477. 110 indexed citations
13.
Schmulewitz, Nathan, Paramvir Singh, Malek M. Safa, & Toni M. Robinson-Smith. (2007). Diagnosis of peritoneal carcinomatosis by EUS-guided FNA. Gastrointestinal Endoscopy. 66(4). 825–826. 2 indexed citations
14.
Safa, Malek M. & Abdul Rahman Jazieh. (2006). Lack of a Uniform Approach to Clinical Research Training for Hematology Oncology Fellows. Journal of Cancer Education. 21(3). 166–168. 4 indexed citations
15.
Lowy, Andrew M., Irfan Firdaus, Debasish Roychowdhury, et al.. (2006). A Phase II Study of Sequential Neoadjuvant Gemcitabine and Paclitaxel, Radiation Therapy With Cisplatin and 5-Fluorouracil and Surgery in Locally Advanced Esophageal Carcinoma. American Journal of Clinical Oncology. 29(6). 555–561. 7 indexed citations
16.
Atiq, Muslim, et al.. (2006). Improvement of survival in VA patients with gall bladder cancer given chemotherapy. Journal of Clinical Oncology. 24(18_suppl). 4132–4132. 1 indexed citations
17.
Safa, Malek M.. (2001). Adjuvant immunotherapy for melanoma and colorectal cancers. Seminars in Oncology. 28(1). 68–92. 20 indexed citations
18.
Safa, Malek M. & Kenneth A. Foon. (2001). Adjuvant immunotherapy for melanoma and colorectal cancers. Seminars in Oncology. 28(1). 68–92. 5 indexed citations
19.
Hungness, Eric S., Malek M. Safa, Elizabeth Shaughnessy, et al.. (2000). Bilateral synchronous breast cancer: Mode of detection and comparison of histologic features between the 2 breasts. Surgery. 128(4). 702–707. 62 indexed citations
20.
Campese, V. M., et al.. (1999). Dietary salt intake, blood pressure and the kidney in hypertensive patients with non-insulin dependent diabetes mellitus.. PubMed. 11(6). 289–95. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monica Zuradelli Breakdown of academic impact, for papers by Piotr Skotnicki Breakdown of academic impact, for papers by J Berlié Breakdown of academic impact, for papers by Piero Fregatti Breakdown of academic impact, for papers by Valeria Forestieri Breakdown of academic impact, for papers by C. De Gislain Breakdown of academic impact, for papers by Nanyan Rao Breakdown of academic impact, for papers by Peter Bojko Breakdown of academic impact, for papers by Prashant Jani Breakdown of academic impact, for papers by C Lejeune
Rankless by CCL
2026